The preclinical data supports ifenprodils role regarding immunomodulatory effects and the cytokines are heavily involved in microvascular permebility (when we think about how acute respiratory distress syndrome is caused by leaky vessels in the lungs secondary to influenza... ifendprodil should stop that same process in COVID)...